Wolverine Trading’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.2K | Buy |
17,703
+758
| +4% | +$563 | ﹤0.01% | 1184 |
|
|
2025
Q1 | $14.2K | Buy |
+16,945
| New | +$14.2K | ﹤0.01% | 1265 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1677 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1477 |
|
|
2024
Q2 | – | Sell |
-15,239
| Closed | -$36.4K | – | 1417 |
|
|
2024
Q1 | $36.4K | Sell |
15,239
-870
| -5% | -$2.08K | ﹤0.01% | 1127 |
|
|
2023
Q4 | $53.6K | Sell |
16,109
-2,399
| -13% | -$7.99K | ﹤0.01% | 1182 |
|
|
2023
Q3 | $69.2K | Sell |
18,508
-7,321
| -28% | -$27.4K | ﹤0.01% | 1036 |
|
|
2023
Q2 | $108K | Buy |
+25,829
| New | +$108K | ﹤0.01% | 918 |
|
|
2023
Q1 | – | Sell |
-15,299
| Closed | -$121K | – | 1240 |
|
|
2022
Q4 | $121K | Buy |
+15,299
| New | +$121K | ﹤0.01% | 813 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1686 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1876 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2036 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1957 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1894 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1563 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1367 |
|
|
2020
Q1 | – | Sell |
-20,912
| Closed | -$367K | – | 1422 |
|
|
2019
Q4 | $367K | Buy |
+20,912
| New | +$367K | ﹤0.01% | 977 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1331 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1408 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1606 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 1502 |
|
|
2017
Q4 | – | Sell |
-15,332
| Closed | -$205K | – | 1650 |
|
|
2017
Q3 | $205K | Buy |
15,332
+3,957
| +35% | +$52.9K | ﹤0.01% | 1039 |
|
|
2017
Q2 | $164K | Buy |
+11,375
| New | +$164K | ﹤0.01% | 1052 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 1348 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 1306 |
|